Balanced

⚠️ Marketing descriptor with no standardized pharmacological definition. In consumer vocabulary, "balanced" most often refers to (a) a 1:1 or near-equivalent THC:CBD ratio, or (b) a subjective experience that lies between "heady" and "body-heavy." Only the first meaning is pharmacologically verifiable via COA cannabinoid assay. Experimental evidence suggests CBD co-administration modestly attenuates THC-induced anxiety, paranoia, and memory impairment (Englund et al. 2013 J Psychopharmacol; Morgan et al. 2010 Br J Psychiatry), supporting a pharmacological rationale for 1:1 products, though RCT evidence is mixed (Freeman et al. 2021 Addiction; Solowij et al. 2019 Transl Psychiatry). The second meaning — "balanced subjective effect" — lacks any validated operationalization and should be treated as expectancy-sensitive marketing language. Citations: Englund A et al. J Psychopharmacol. 2013;27:19-27; Morgan CJA et al. Br J Psychiatry. 2010;197:285-290; Freeman AM et al. Addiction. 2021.